Agenda Profile: Urve Tiidus

Draft law amending the Medicinal Products Act (501 SE) – First Reading

2024-10-24

15th Riigikogu, 4th sitting, plenary session

Political Position
The political focus is on the amendments to the Medicinal Products Act (Bill 501 SE). The speaker attempts to affirm that the bill is motivated by a pragmatic need arising from practical experience, which suggests a policy-driven approach. The position is one of inquiry and seeking clarification, neither supportive nor oppositional.

1 Speeches Analyzed
Topic Expertise
The knowledge is related to the reasons for initiating the draft amendments (501 SE) to the Medicinal Products Act. The speaker emphasizes the concept of "practical life necessity" as the impetus for the legal amendments. There is a lack of evidence regarding the use of technical terminology, data, or deep specialized knowledge.

1 Speeches Analyzed
Rhetorical Style
The speaker's style is polite and formal, addressing the minister directly ("Esteemed Minister!"). The rhetoric is analytical and focuses on obtaining clarification, employing the form of a direct question. The tone is neutral and businesslike.

1 Speeches Analyzed
Activity Patterns
The information is restricted to asking a single question during the first reading of the Draft Medicines Act in the Riigikogu.

1 Speeches Analyzed
Opposition Stance
Insufficient information

1 Speeches Analyzed
Collaboration Style
The style of cooperation is respectful and constructive, addressing the minister directly to seek clarification. This signals a readiness for dialogue with the government concerning the objectives of the bill.

1 Speeches Analyzed
Regional Focus
Insufficient information

1 Speeches Analyzed
Economic Views
Insufficient information

1 Speeches Analyzed
Social Issues
The focus is on the Medicinal Products Act, which addresses the social aspect of healthcare. Specific positions on broader social issues (e.g., education, security) are absent.

1 Speeches Analyzed
Legislative Focus
The primary legislative focus is on the draft Act amending the Medicinal Products Act (501 SE). The speaker's role is to confirm and clarify the reasons for initiating the bill, emphasizing the practical necessity.

1 Speeches Analyzed